GRAF JAMES A (Chief Executive Officer) purchased 0.1% of their position (5K shares) of NKGEN BIOTECH, INC. on the open market
Open‑market purchase worth $49.5K — a small addition. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 6/3/2021ACC: 0001104659-21-076032
Officer10% Owner· Chief Executive Officer
Since May 2021
+5K
Net shares
Net buyer
$49.5K
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
5K acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+1.82K
Price / share
$9.90
Trade value
$18K
% of position
0.0%
5/28/2021
4.23M→4.23M
Common Stock
Direct
Shares
+3.18K
Price / share
$9.90
Trade value
$31.50K
% of position
0.1%
6/1/2021
4.23M→4.24M
Total
Net shares
+5K
Net value
$49.50K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/28/2021 | P · Purchase | +1.82K | $9.90 | $18K | 0.0% | 4.23M | 4.23M |
| Common Stock Direct | 6/1/2021 | P · Purchase | +3.18K | $9.90 | $31.50K | 0.1% | 4.23M | 4.24M |
| Total | +5K | $49.50K | ||||||
Derivative Transactions0
No derivative transactions reported